Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

APMD

Apnimed Inc

25.00

Aug 03 • 3:59 PM ET 0.00 (0.00%)

25.10

Aftermarket • 7:57 PM ET +0.10 (0.40%)

Healthcare Biotechnology USA Small NASD

Today, 4:40 PMApnimed announces the closing of its upsized initial public offering, including full exercise of the underwriters’ option, for total gross proceeds of $220.8 million.

Held by: JDOC

Scroll to Statements

Index	-
Market Cap	950.00M
Enterprise Value	1.19B
Income	-
Sales	-
Book/sh	-8.00
Cash/sh	1.23
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Jul 31, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	20.26
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	1.82
Current Ratio	1.82
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	-69.75% -
Sales past 3/5Y	237.57% -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	-
Insider Trans	-
Inst Own	-
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	0.00%
SMA50	0.00%
SMA200	0.00%
Trades

Shs Outstand	38.00M
Shs Float	-
Short Float	-
Short Ratio	-
Short Interest	-
52W High	29.15 -14.24%
52W Low	16.12 55.09%
Volatility	- -
ATR (14)	9.29
RSI (14)	-
Beta	-
Rel Volume	0.20
Avg Volume	3.44M
Volume	700,677

Perf Week	-
Perf Month	-
Perf Quarter	-
Perf Half Y	-
Perf YTD	13.64%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	25.00
Price	25.00
Change	0.00%

Today 04:35PM

Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

(GlobeNewswire)

Apnimed, Inc. operates as a clinical-stage company. It engages in the discovery, development, and commercialization of oral therapies for sleep-related breathing diseases. The company was founded by Lawrence G. Miller, Barry Wohl and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.

CEO & DirectorMr. Kevin R. Lind

M.P.H.Dr. Lawrence G. Miller M.D.

President & COOMr. Dennis P. Molnar M.B.A.

Senior Manager of AdministrationMs. Leila Sylvain

Ph.D.Dr. Sean M. Johnston M.B.A.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SEKHRI PAUL J	Director	Aug 03 '26	Buy	16.00	12,500	200,000	12,500	Aug 03 04:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

APMD

Apnimed Inc

Upgrade your Finviz experience